nodes	percent_of_prediction	percent_of_DWPC	metapath
Trametinib—MAP2K2—Downstream signal transduction—FGFR3—cleft lip	0.00107	0.00107	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by VEGF—NOS3—cleft lip	0.00106	0.00106	CbGpPWpGaD
Trametinib—MAP2K1—Downstream signaling of activated FGFR—FGFR3—cleft lip	0.00106	0.00106	CbGpPWpGaD
Trametinib—MAP2K1—Regulation of Actin Cytoskeleton—FGFR3—cleft lip	0.00106	0.00106	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by FGFR—FGFR3—cleft lip	0.00106	0.00106	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by NGF—FGF9—cleft lip	0.00106	0.00106	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by ERBB2—FGFR3—cleft lip	0.00106	0.00106	CbGpPWpGaD
Trametinib—MAP2K1—Downstream signal transduction—FGFR1—cleft lip	0.00106	0.00106	CbGpPWpGaD
Trametinib—MAP2K1—VEGFA-VEGFR2 Pathway—NOS3—cleft lip	0.00105	0.00105	CbGpPWpGaD
Trametinib—MAP2K2—DAP12 signaling—FGFR3—cleft lip	0.00105	0.00105	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by FGFR—FGFR1—cleft lip	0.00105	0.00105	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by FGFR in disease—FGFR2—cleft lip	0.00105	0.00105	CbGpPWpGaD
Trametinib—MAP2K1—Fc epsilon receptor (FCERI) signaling—FGFR2—cleft lip	0.00105	0.00105	CbGpPWpGaD
Trametinib—MAP2K1—DAP12 interactions—FGFR2—cleft lip	0.00105	0.00105	CbGpPWpGaD
Trametinib—MAP2K2—DAP12 interactions—FGFR1—cleft lip	0.00105	0.00105	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by FGFR in disease—FGFR1—cleft lip	0.00105	0.00105	CbGpPWpGaD
Trametinib—MAP2K2—Fc epsilon receptor (FCERI) signaling—FGFR1—cleft lip	0.00105	0.00105	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by ERBB2—FGFR1—cleft lip	0.00104	0.00104	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by ERBB4—FGFR3—cleft lip	0.00104	0.00104	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by EGFR—FGFR2—cleft lip	0.00104	0.00104	CbGpPWpGaD
Trametinib—MAP2K1—DAP12 signaling—FGFR1—cleft lip	0.00104	0.00104	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by EGFR—FGFR1—cleft lip	0.00104	0.00104	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by EGFR in Cancer—FGFR2—cleft lip	0.00103	0.00103	CbGpPWpGaD
Trametinib—MAP2K1—TSH signaling pathway—MYC—cleft lip	0.00103	0.00103	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by EGFR in Cancer—FGFR1—cleft lip	0.00103	0.00103	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by PDGF—FGFR2—cleft lip	0.00103	0.00103	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by PDGF—FGFR1—cleft lip	0.00102	0.00102	CbGpPWpGaD
Trametinib—MAP2K1—MAPK Signaling Pathway—FGFR1—cleft lip	0.00102	0.00102	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by Insulin receptor—FGF2—cleft lip	0.001	0.001	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—WNT9B—cleft lip	0.000998	0.000998	CbGpPWpGaD
Trametinib—MAP2K1—Downstream signal transduction—FGFR3—cleft lip	0.000997	0.000997	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by VEGF—NOS3—cleft lip	0.000995	0.000995	CbGpPWpGaD
Trametinib—MAP2K2—NGF signalling via TRKA from the plasma membrane—FGFR2—cleft lip	0.000994	0.000994	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by FGFR—FGFR3—cleft lip	0.000992	0.000992	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by FGFR in disease—FGFR3—cleft lip	0.000988	0.000988	CbGpPWpGaD
Trametinib—MAP2K2—DAP12 interactions—FGFR3—cleft lip	0.000988	0.000988	CbGpPWpGaD
Trametinib—MAP2K2—Fc epsilon receptor (FCERI) signaling—FGFR3—cleft lip	0.000988	0.000988	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by ERBB2—FGFR3—cleft lip	0.000987	0.000987	CbGpPWpGaD
Trametinib—MAP2K1—DAP12 signaling—FGFR3—cleft lip	0.000983	0.000983	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by EGFR—FGFR3—cleft lip	0.000979	0.000979	CbGpPWpGaD
Trametinib—MAP2K1—DAP12 interactions—FGFR1—cleft lip	0.000978	0.000978	CbGpPWpGaD
Trametinib—MAP2K1—Fc epsilon receptor (FCERI) signaling—FGFR1—cleft lip	0.000978	0.000978	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by FGFR in disease—FGFR1—cleft lip	0.000978	0.000978	CbGpPWpGaD
Trametinib—CYP2C8—Biological oxidations—MTR—cleft lip	0.000971	0.000971	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by EGFR in Cancer—FGFR3—cleft lip	0.000971	0.000971	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by EGFR—FGFR1—cleft lip	0.000969	0.000969	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by PDGF—FGFR3—cleft lip	0.000966	0.000966	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by EGFR in Cancer—FGFR1—cleft lip	0.000961	0.000961	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by PDGF—FGFR1—cleft lip	0.000957	0.000957	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by NGF—FGF10—cleft lip	0.000952	0.000952	CbGpPWpGaD
Trametinib—MAP2K1—NGF signalling via TRKA from the plasma membrane—FGFR2—cleft lip	0.00093	0.00093	CbGpPWpGaD
Trametinib—MAP2K2—NGF signalling via TRKA from the plasma membrane—FGFR1—cleft lip	0.000926	0.000926	CbGpPWpGaD
Trametinib—MAP2K1—Fc epsilon receptor (FCERI) signaling—FGFR3—cleft lip	0.000924	0.000924	CbGpPWpGaD
Trametinib—MAP2K1—DAP12 interactions—FGFR3—cleft lip	0.000924	0.000924	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by FGFR in disease—FGFR3—cleft lip	0.000924	0.000924	CbGpPWpGaD
Trametinib—MAP2K1—Integrated Pancreatic Cancer Pathway—FGFR1—cleft lip	0.00092	0.00092	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by EGFR—FGFR3—cleft lip	0.000916	0.000916	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by SCF-KIT—FGF2—cleft lip	0.000916	0.000916	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by EGFR in Cancer—FGFR3—cleft lip	0.000908	0.000908	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by PDGF—FGFR3—cleft lip	0.000904	0.000904	CbGpPWpGaD
Trametinib—MAP2K2—Disease—WNT9B—cleft lip	0.0009	0.0009	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by NGF—FGF10—cleft lip	0.000891	0.000891	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—FGF7—cleft lip	0.000879	0.000879	CbGpPWpGaD
Trametinib—MAP2K2—Downstream signaling of activated FGFR—FGF2—cleft lip	0.000876	0.000876	CbGpPWpGaD
Trametinib—MAP2K2—Regulation of Actin Cytoskeleton—FGF2—cleft lip	0.000876	0.000876	CbGpPWpGaD
Trametinib—MAP2K2—NGF signalling via TRKA from the plasma membrane—FGFR3—cleft lip	0.000875	0.000875	CbGpPWpGaD
Trametinib—MAP2K1—NGF signalling via TRKA from the plasma membrane—FGFR1—cleft lip	0.000866	0.000866	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by ERBB4—FGF2—cleft lip	0.000863	0.000863	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by SCF-KIT—FGF2—cleft lip	0.000857	0.000857	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—WNT3—cleft lip	0.000847	0.000847	CbGpPWpGaD
Trametinib—MAP2K1—Disease—WNT9B—cleft lip	0.000842	0.000842	CbGpPWpGaD
Trametinib—MAP2K2—Downstream signal transduction—FGF2—cleft lip	0.000824	0.000824	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—FGF7—cleft lip	0.000822	0.000822	CbGpPWpGaD
Trametinib—MAP2K1—Downstream signaling of activated FGFR—FGF2—cleft lip	0.00082	0.00082	CbGpPWpGaD
Trametinib—MAP2K1—Regulation of Actin Cytoskeleton—FGF2—cleft lip	0.00082	0.00082	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by FGFR—FGF2—cleft lip	0.00082	0.00082	CbGpPWpGaD
Trametinib—MAP2K1—NGF signalling via TRKA from the plasma membrane—FGFR3—cleft lip	0.000819	0.000819	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—IRF6—cleft lip	0.000817	0.000817	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by ERBB2—FGF2—cleft lip	0.000816	0.000816	CbGpPWpGaD
Trametinib—MAP2K2—DAP12 signaling—FGF2—cleft lip	0.000812	0.000812	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—FGF8—cleft lip	0.000811	0.000811	CbGpPWpGaD
Trametinib—MAP2K2—EGF/EGFR Signaling Pathway—NOS3—cleft lip	0.000808	0.000808	CbGpPWpGaD
Trametinib—MAP2K2—B Cell Receptor Signaling Pathway—MYC—cleft lip	0.000808	0.000808	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by ERBB4—FGF2—cleft lip	0.000807	0.000807	CbGpPWpGaD
Trametinib—MAP2K2—Disease—ABCA4—cleft lip	0.000802	0.000802	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—WNT3—cleft lip	0.000793	0.000793	CbGpPWpGaD
Trametinib—MAP2K1—Downstream signal transduction—FGF2—cleft lip	0.000771	0.000771	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by FGFR—FGF2—cleft lip	0.000767	0.000767	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—IRF6—cleft lip	0.000764	0.000764	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by NGF—FGFR2—cleft lip	0.000764	0.000764	CbGpPWpGaD
Trametinib—MAP2K2—DAP12 interactions—FGF2—cleft lip	0.000764	0.000764	CbGpPWpGaD
Trametinib—MAP2K2—Fc epsilon receptor (FCERI) signaling—FGF2—cleft lip	0.000764	0.000764	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by FGFR in disease—FGF2—cleft lip	0.000764	0.000764	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by ERBB2—FGF2—cleft lip	0.000763	0.000763	CbGpPWpGaD
Trametinib—MAP2K1—DAP12 signaling—FGF2—cleft lip	0.000759	0.000759	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—FGF8—cleft lip	0.000759	0.000759	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by EGFR—FGF2—cleft lip	0.000757	0.000757	CbGpPWpGaD
Trametinib—MAP2K1—EGF/EGFR Signaling Pathway—NOS3—cleft lip	0.000756	0.000756	CbGpPWpGaD
Trametinib—MAP2K1—B Cell Receptor Signaling Pathway—MYC—cleft lip	0.000756	0.000756	CbGpPWpGaD
Trametinib—MAP2K1—Disease—ABCA4—cleft lip	0.00075	0.00075	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by EGFR in Cancer—FGF2—cleft lip	0.00075	0.00075	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by PDGF—FGF2—cleft lip	0.000747	0.000747	CbGpPWpGaD
Trametinib—MAP2K2—Disease—SLC19A1—cleft lip	0.000734	0.000734	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by NGF—FGFR2—cleft lip	0.000715	0.000715	CbGpPWpGaD
Trametinib—MAP2K2—Disease—WNT3—cleft lip	0.000715	0.000715	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by FGFR in disease—FGF2—cleft lip	0.000714	0.000714	CbGpPWpGaD
Trametinib—MAP2K1—Fc epsilon receptor (FCERI) signaling—FGF2—cleft lip	0.000714	0.000714	CbGpPWpGaD
Trametinib—MAP2K1—DAP12 interactions—FGF2—cleft lip	0.000714	0.000714	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by NGF—FGFR1—cleft lip	0.000712	0.000712	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by EGFR—FGF2—cleft lip	0.000708	0.000708	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by EGFR in Cancer—FGF2—cleft lip	0.000702	0.000702	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by PDGF—FGF2—cleft lip	0.000699	0.000699	CbGpPWpGaD
Trametinib—MAP2K1—Disease—SLC19A1—cleft lip	0.000686	0.000686	CbGpPWpGaD
Trametinib—MAP2K2—NGF signalling via TRKA from the plasma membrane—FGF2—cleft lip	0.000676	0.000676	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by NGF—FGFR3—cleft lip	0.000673	0.000673	CbGpPWpGaD
Trametinib—MAP2K1—Integrated Pancreatic Cancer Pathway—FGF2—cleft lip	0.000672	0.000672	CbGpPWpGaD
Trametinib—MAP2K1—Disease—WNT3—cleft lip	0.000669	0.000669	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by NGF—FGFR1—cleft lip	0.000666	0.000666	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—FGF3—cleft lip	0.00066	0.00066	CbGpPWpGaD
Trametinib—MAP2K2—PDGFR-beta signaling pathway—MYC—cleft lip	0.000659	0.000659	CbGpPWpGaD
Trametinib—MAP2K2—Axon guidance—FGFR1—cleft lip	0.000645	0.000645	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—FGF9—cleft lip	0.000644	0.000644	CbGpPWpGaD
Trametinib—MAP2K1—NGF signalling via TRKA from the plasma membrane—FGF2—cleft lip	0.000633	0.000633	CbGpPWpGaD
Trametinib—MAP2K2—TGF-beta Signaling Pathway—MYC—cleft lip	0.000631	0.000631	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—WNT9B—cleft lip	0.00063	0.00063	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by NGF—FGFR3—cleft lip	0.00063	0.00063	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—FGF3—cleft lip	0.000618	0.000618	CbGpPWpGaD
Trametinib—MAP2K1—PDGFR-beta signaling pathway—MYC—cleft lip	0.000617	0.000617	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—FGF10—cleft lip	0.000615	0.000615	CbGpPWpGaD
Trametinib—MAP2K2—Disease—TCN2—cleft lip	0.000608	0.000608	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—NOG—cleft lip	0.000604	0.000604	CbGpPWpGaD
Trametinib—MAP2K1—Axon guidance—FGFR1—cleft lip	0.000603	0.000603	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—FGF9—cleft lip	0.000602	0.000602	CbGpPWpGaD
Trametinib—MAP2K1—TGF-beta Signaling Pathway—MYC—cleft lip	0.000591	0.000591	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—WNT9B—cleft lip	0.00059	0.00059	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—FGF10—cleft lip	0.000575	0.000575	CbGpPWpGaD
Trametinib—MAP2K1—Disease—TCN2—cleft lip	0.000569	0.000569	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—NOG—cleft lip	0.000565	0.000565	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—ABCA4—cleft lip	0.000562	0.000562	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—SUMO1—cleft lip	0.00056	0.00056	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—FGF10—cleft lip	0.000543	0.000543	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—ABCA4—cleft lip	0.000526	0.000526	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—SUMO1—cleft lip	0.000524	0.000524	CbGpPWpGaD
Trametinib—CYP3A4—Biological oxidations—MTR—cleft lip	0.000521	0.000521	CbGpPWpGaD
Trametinib—MAP2K2—MAPK Signaling Pathway—MYC—cleft lip	0.00052	0.00052	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by NGF—FGF2—cleft lip	0.00052	0.00052	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—FGF7—cleft lip	0.000512	0.000512	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—FGF10—cleft lip	0.000508	0.000508	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—WNT3—cleft lip	0.000501	0.000501	CbGpPWpGaD
Trametinib—MAP2K1—MAPK Signaling Pathway—MYC—cleft lip	0.000487	0.000487	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by NGF—FGF2—cleft lip	0.000487	0.000487	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—FGF7—cleft lip	0.000479	0.000479	CbGpPWpGaD
Trametinib—MAP2K2—Disease—FGF7—cleft lip	0.000473	0.000473	CbGpPWpGaD
Trametinib—MAP2K2—Disease—SPRY2—cleft lip	0.000473	0.000473	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—FGF8—cleft lip	0.000473	0.000473	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—WNT3—cleft lip	0.000468	0.000468	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—PTCH1—cleft lip	0.000464	0.000464	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—FGFR1—cleft lip	0.00046	0.00046	CbGpPWpGaD
Trametinib—MAP2K1—Disease—FGF7—cleft lip	0.000442	0.000442	CbGpPWpGaD
Trametinib—MAP2K1—Disease—SPRY2—cleft lip	0.000442	0.000442	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—FGF8—cleft lip	0.000442	0.000442	CbGpPWpGaD
Trametinib—MAP2K1—Integrated Pancreatic Cancer Pathway—MYC—cleft lip	0.000439	0.000439	CbGpPWpGaD
Trametinib—MAP2K2—Disease—FGF8—cleft lip	0.000436	0.000436	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—FGFR2—cleft lip	0.000436	0.000436	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—PTCH1—cleft lip	0.000434	0.000434	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—FGFR1—cleft lip	0.00043	0.00043	CbGpPWpGaD
Trametinib—MAP2K2—Disease—MTR—cleft lip	0.000421	0.000421	CbGpPWpGaD
Trametinib—MAP2K1—Disease—FGF8—cleft lip	0.000408	0.000408	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—FGFR2—cleft lip	0.000408	0.000408	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—FGFR1—cleft lip	0.000406	0.000406	CbGpPWpGaD
Trametinib—MAP2K1—Disease—MTR—cleft lip	0.000394	0.000394	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—FGF3—cleft lip	0.000385	0.000385	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—FGFR3—cleft lip	0.000384	0.000384	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—FGFR1—cleft lip	0.00038	0.00038	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—FGF9—cleft lip	0.000375	0.000375	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—FGF3—cleft lip	0.00036	0.00036	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—FGFR3—cleft lip	0.000359	0.000359	CbGpPWpGaD
Trametinib—MAP2K2—Disease—FGF3—cleft lip	0.000355	0.000355	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—FGF9—cleft lip	0.000351	0.000351	CbGpPWpGaD
Trametinib—MAP2K2—Disease—FGF9—cleft lip	0.000346	0.000346	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—FGF2—cleft lip	0.000336	0.000336	CbGpPWpGaD
Trametinib—MAP2K1—Disease—FGF3—cleft lip	0.000332	0.000332	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—SPRY2—cleft lip	0.000331	0.000331	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—FGF7—cleft lip	0.000331	0.000331	CbGpPWpGaD
Trametinib—MAP2K1—Disease—FGF9—cleft lip	0.000324	0.000324	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—FGF10—cleft lip	0.000316	0.000316	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—FGF2—cleft lip	0.000314	0.000314	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—SPRY2—cleft lip	0.00031	0.00031	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—FGF7—cleft lip	0.00031	0.00031	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—FGF8—cleft lip	0.000306	0.000306	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—FGF2—cleft lip	0.000297	0.000297	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—FGF10—cleft lip	0.000296	0.000296	CbGpPWpGaD
Trametinib—MAP2K2—Disease—FGF10—cleft lip	0.000292	0.000292	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—SLC19A1—cleft lip	0.000289	0.000289	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—FGF8—cleft lip	0.000286	0.000286	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—FGF2—cleft lip	0.000278	0.000278	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—PTCH1—cleft lip	0.000274	0.000274	CbGpPWpGaD
Trametinib—MAP2K1—Disease—FGF10—cleft lip	0.000273	0.000273	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—PTCH1—cleft lip	0.000257	0.000257	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—FGFR2—cleft lip	0.000254	0.000254	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—FGF3—cleft lip	0.000249	0.000249	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—FGF9—cleft lip	0.000242	0.000242	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—TCN2—cleft lip	0.00024	0.00024	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—FGFR2—cleft lip	0.000238	0.000238	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—FGFR1—cleft lip	0.000237	0.000237	CbGpPWpGaD
Trametinib—MAP2K2—Disease—FGFR2—cleft lip	0.000234	0.000234	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—FGF3—cleft lip	0.000233	0.000233	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—FGF9—cleft lip	0.000227	0.000227	CbGpPWpGaD
Trametinib—MAP2K2—Disease—MTHFR—cleft lip	0.000226	0.000226	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—FGFR3—cleft lip	0.000224	0.000224	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—FGFR1—cleft lip	0.000221	0.000221	CbGpPWpGaD
Trametinib—MAP2K1—Disease—FGFR2—cleft lip	0.000219	0.000219	CbGpPWpGaD
Trametinib—MAP2K2—Disease—FGFR1—cleft lip	0.000218	0.000218	CbGpPWpGaD
Trametinib—MAP2K1—Disease—MTHFR—cleft lip	0.000211	0.000211	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—FGFR3—cleft lip	0.000209	0.000209	CbGpPWpGaD
Trametinib—MAP2K2—Disease—FGFR3—cleft lip	0.000206	0.000206	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—FGF10—cleft lip	0.000205	0.000205	CbGpPWpGaD
Trametinib—MAP2K1—Disease—FGFR1—cleft lip	0.000204	0.000204	CbGpPWpGaD
Trametinib—MAP2K1—Disease—FGFR3—cleft lip	0.000193	0.000193	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—FGF10—cleft lip	0.000191	0.000191	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—FGF2—cleft lip	0.000173	0.000173	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—MTR—cleft lip	0.000166	0.000166	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—FGFR2—cleft lip	0.000164	0.000164	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—FGF2—cleft lip	0.000162	0.000162	CbGpPWpGaD
Trametinib—MAP2K2—Disease—FGF2—cleft lip	0.00016	0.00016	CbGpPWpGaD
Trametinib—MAP2K2—Disease—NOS3—cleft lip	0.000157	0.000157	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—SLC19A1—cleft lip	0.000155	0.000155	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—FGFR2—cleft lip	0.000154	0.000154	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—FGFR1—cleft lip	0.000153	0.000153	CbGpPWpGaD
Trametinib—MAP2K1—Disease—FGF2—cleft lip	0.000149	0.000149	CbGpPWpGaD
Trametinib—MAP2K1—Disease—NOS3—cleft lip	0.000147	0.000147	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—FGFR3—cleft lip	0.000145	0.000145	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—FGFR1—cleft lip	0.000143	0.000143	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—FGFR3—cleft lip	0.000135	0.000135	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—TCN2—cleft lip	0.000129	0.000129	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—FGF2—cleft lip	0.000112	0.000112	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—NOS3—cleft lip	0.00011	0.00011	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—FGF2—cleft lip	0.000105	0.000105	CbGpPWpGaD
Trametinib—MAP2K2—Disease—MYC—cleft lip	0.000104	0.000104	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—NOS3—cleft lip	0.000103	0.000103	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—TYMS—cleft lip	0.000102	0.000102	CbGpPWpGaD
Trametinib—MAP2K1—Disease—MYC—cleft lip	9.76e-05	9.76e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—MTR—cleft lip	8.92e-05	8.92e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—MTHFR—cleft lip	8.9e-05	8.9e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—MYC—cleft lip	7.3e-05	7.3e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—MYC—cleft lip	6.83e-05	6.83e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—NOS3—cleft lip	6.2e-05	6.2e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—TYMS—cleft lip	5.47e-05	5.47e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—MTHFR—cleft lip	4.77e-05	4.77e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—NOS3—cleft lip	3.33e-05	3.33e-05	CbGpPWpGaD
